EC-Cap-SC: Endocuff-assisted Versus Cap-assisted Versus Standard Colonoscopy
Study Details
Study Description
Brief Summary
Comparison of Endocuff-assisted, Cap-assisted and Standard colonoscopy for assessment of the adenoma detection rate (ADR)
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The Endocuff is a medical device, approved in 2012 by the American Food and Drug Administration, which was also authorized by the European Agency for the Evaluation of Medicinal Products. The aim of the cuff is to optimize the view of the colonic mucosa. There is also a transparent cap on the market, which is used in colonoscopy for a better evaluation of the mucosa and polyp detection. The goal of this project is to conduct a prospective randomized trial for clarification of the hypotheses, whether the usage of the Endocuff increases the detection rate of adenomas compared to the transparent cap or compared to standard colonoscopy.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Arc Endocuff (AEC 110, 120, 130, 140) Endocuff-assisted colonoscopy Colonoscopy with the Endocuff attached at the distal tip of the scope |
Device: Arc Endocuff (AEC 110, 120, 130, 140)
|
Active Comparator: Cap Cap-assisted colonoscopy Colonoscopy with the transparent Cap attached at the distal tip of the scope |
Device: Cap
Olympus Disposable distal attachment 15mm diameter, 4mm depth
|
Active Comparator: Standard Colonoscope Standard colonoscopy without any additional device |
Device: Standard colonoscope
|
Outcome Measures
Primary Outcome Measures
- Adenoma detection rate [1 year]
Proportion of patients having at least one adenoma
- Polyp detection rate [1 year]
Proportion of patients having at least one adenoma
Secondary Outcome Measures
- Bowel preparation result [one day]
- Coecum intubation rate [one year]
- Ileum intubation rate [one year]
- Coecum intubation time [one day]
- withdrawal time [one day]
- mucosal laceration [one day]
- severe bleeding [one day]
- perforation [one day]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Colonoscopy independent from indication
-
Age ≥ 18
-
Patient is able to provide informed consent for the procedure
Exclusion Criteria:
-
Inflammatory Bowel Disease stenosis
-
Pregnant of nursing patient
-
Acute diverticulitis
-
Active Inflammatory Bowel Disease
-
Age ≤ 18
-
Coagulation disorder (INR>1.4 , Thrombocytes < 50000/µl)
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Muenster | Muenster | North-Rhine Westphalia | Germany | 48149 |
2 | University Medical Center Göttingen | Göttingen | Germany | 37075 | |
3 | HELIOS St. Marienberg Klinik Helmstedt | Helmstedt | Germany | ||
4 | HELIOS Albert-Schweitzer-Klinik | Northeim | Germany | 37154 | |
5 | HELIOS Medical Center Siegburg | Siegburg | Germany | ||
6 | Wroclaw Medical University | Wroclaw | Poland | 50-556 |
Sponsors and Collaborators
- Helios Albert-Schweitzer-Klinik Northeim
Investigators
- Principal Investigator: Tobias Meister, Prof. Dr.med., Helios Albert-Schweitzer-Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- EC-CUFF-2015